Skip to main content
SpringerLink
Log in

Inhibition of tumor invasiveness by 1-alpha-25-dihydroxy-vitamin D coupled to a decline in protein kinase A activity and an increase in cytoskeletal organization

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

The capacity of cloned metastatic Lewis lung carcinoma cells (LLC-LN7) to invade through reconstituted basement membrane-coated filters was reduced after incubation with 1α,25-dihydroxyvitamin D [1,25(OH)D]. This was observed at doses as low as 10 m 1,25(OH)D. The 1,25(OH)D-treated cells also had reduced levels of protein kinase A (PKA) activity and an increase in the level of polymerized actin, properties that have previously been demonstrated for less metastatic LLC variants. In addition, levels of the intermediate filament protein vimentin increased in 1,25(OH)D-treated LLC-LN7 tumor cells. In contrast, the levels and distribution of tubulin were not affected by 1,25(OH)D. The possibility that the decline in PKA activity was involved in the 1,25(OH)D modulation of the cytoskeletal components was evaluated. To accomplish this, LLC-7 transfectants whose PKA levels were blocked due to expression of a mutated PKA R subunit (LN7-REV) were incubated with 1,25(OH)D and their levels of F-actin were measured. In the absence of 1,25(OH)D treatment, the PKA-defective LN7-REV cells had an increased level of polymerized actin as compared to the wild-type LLC-LN7 cells. This level of F-actin was minimally affected by 1,25(OH)D, suggesting that PKA activity is required for 1,25(OH)D modulation of actin polymerization. These studies show that 1,25(OH)D can reduce PKA activity in tumor cells, and that this reduction in PKA may be an intermediate signal through which 1,25(OH)D affects the cytoskeleton and diminishes tumor invasiveness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bernstein LR and Liotta LA, 1994, Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr Opin Oncol, 6,106–13.

    Google Scholar 

  2. Rosen EM, Knesel J, Goldberg ID, et al.1994, Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int J Cancer, 57,706–14.

    Google Scholar 

  3. You J, Miele ME, Dong C and Welch DR, 1995, Suppression of human melanoma metastasis by introduction of chromosome 6 may be partially due to inhibition of motility, but not to inhibition of invasion. Biochem Biophys Res Commun, 208,476–84.

    Google Scholar 

  4. Veatch AL, Carson LF and Ramakrishnan S, 1995, Phenotypic variations and differential migration of NIH:OVCAR-3 ovarian carcinoma cells isolated from athymic mice. Clin Exp Metastasis, 13, 165–72.

    Google Scholar 

  5. Mohler JL, Broskie EN, Ranparia DJ, Sharief Y, Coleman WB and Smith GJ, 1992, Cancer cell motility-inhibitory protein in the Dunning adenocarcinoma model. Cancer Res, 52,2349–52.

    Google Scholar 

  6. Shimokawa-Kuroki R, Sadano H and Taniguchi S, 1994, A variant actin (beta m) reduces metastasis of mouse B16 melanoma. Int J Cancer, 56,689–97.

    Google Scholar 

  7. Sadano H, Shimokawa-Kuroki R and Taniguchi S, 1994, Intracellular localization and biochemical function of variant beta-actin, which inhibits metastasis of B16 melanoma. Japanese J Cancer Res, 85,735–43.

    Google Scholar 

  8. Pokorna E, Jordan PW, O'Neill CH, Zicha D, Gilbert CS and Vesely P, 1994, Actin cytoskeleton and motility in rat sarcoma cell populations with different metastatic potential. Cell Motility & the Cytoskeleton, 28,25–33.

    Google Scholar 

  9. Helige C, Smolle J, Zellnig G, et al.1993, Inhibition of K1735-M2 melanoma cell invasion tiin vitroby retinoic acid. Clin Exp Met, 11,409–18.

    Google Scholar 

  10. Lakshmi MS, Parker C and Sherbet GV, 1993, Metastasis and associated MTS1 and NM23 genes affect tubulin polymerisation in B16 melanomas: a possible mechanism of their regulation of metastatic behaviour of tumours. Anticancer Res, 13,299–303.

    Google Scholar 

  11. Button E, Shapland C and Lawson D, 1995, Actin, its associated proteins and metastasis. Cell Motil Cytoskel, 30,247–51.

    Google Scholar 

  12. Imai K, Kumagai S, Nakagawa K, Yamamoto E, Nakanishi I and Okada Y, 1995, Immunolocalization of desmoglein and intermediate filaments in human oral squamous cell carcinomas. Head & Neck, 17,204–12.

    Google Scholar 

  13. Scott G and Liang H, 1995, pp125FAK in human melanocytes and melanoma: expression and phosphorylation. Exp Cell Res, 219,197–203.

    Google Scholar 

  14. Trachsel S and Keller HU, 1995, Selective responses (actin polymerization, shape changes, locomotion, pinocytosis) to the PKC inhibitor Ro 31-8220 suggest that PKC discriminately regulates functions of human blood lymphocytes. J Leuko Biol, 57,587–91.

    Google Scholar 

  15. Goldenring JR, Vallano ML and DeLorenzo RJ, 1985, Phosphorylation of microtubule-associated protein 2 at distinct sites by calmodulin-dependent and cyclic-AMP-dependent kinases. J Neurochem, 45,900–5.

    Google Scholar 

  16. Johnson GV and Foley VG, 1993, Calpain-mediated proteolysis of microtubule-associated protein 2 (MAP-2) is inhibited by phosphorylation by cAMPdependent protein kinase, but not by Ca2+/calmodulindependent protein kinase II. J Neurosci Res, 34,642–7.

    Google Scholar 

  17. Lamb NJC, Fernandez A, Feramisco JR and Welch WJ, 1989, Modulation of vimentin containing intermediate filament distribution and phosphorylation in living fibroblasts by the cAMP-dependent protein kinase. J Cell Biol, 108,2409–22.

    Google Scholar 

  18. Huang TJ, Lee TT, Lee WC, Lai YK, Yu JS and Yang SD, 1994, Autophosphorylation-dependent protein kinase phosphorylates Ser25, Ser38, Ser65, Ser71, and Ser411 in vimentin and thereby inhibits cytoskeletal intermediate filament assembly. J Prot Chem, 13,517–25.

    Google Scholar 

  19. Tang DG, Grossi IM, Tang KQ, Diglio CA and Honn KV, 1995, Inhibition of TPA and 12(S)-HETE-stimulated tumor cell adhesion by prostacyclin and its stable analogs: rationale for their antimetastatic effects. Int J Cancer, 60,418–25.

    Google Scholar 

  20. Ziegler A, Knesel J, Fabbro D and Nagamine Y, 1991, Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells. J Biol Chem, 266,21067–74.

    Google Scholar 

  21. Young MRI, Duffie GP, Lozano Y, Young ME and Wright MA, 1990, Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants. Cancer Res, 50,2973–8.

    Google Scholar 

  22. Young MRI, Lozano Y, Djordjevic A and Maier D, 1993, Protein phosphatases limit tumor motility. Int J Cancer, 54,1036–41.

    Google Scholar 

  23. Maier GD, Vellody K, Meisinger J, Djordjevic A, Lozano Y and Young MRI, 1996, Protein kinase A regulates Lewis lung carcinoma adherence to extracellular matrix components and spontaneous metastasis. Clin Exp Metastasis, in press.

  24. Young MRI, Montpetit M, Lozano Y, et al.1995, Lewis lung carcinoma transfectants that either overexpress or have defective protein kinase A activity have a respective high or low capacity to invade and metastasize tiin vivo. Int J Cancer, 64,104–9.

    Google Scholar 

  25. Young MRI, Young ME, Lozano Y, Coogan M and Bagash JM, 1991, Regulation of protein kinase A activation and prostaglandin E2-stimulated migration of Lewis lung carcinoma clones. Int J Cancer, 49,150–5.

    Google Scholar 

  26. Young MRI, Halpin J, Hussain R, et al.1993, Inhibition of tumor production of granulocyte-macrophage colony-stimulating factor by 1α,25-dihydroxyvitamin D3 reduces tumor motility and metastasis. Invasion Metastasis, 13,169–77.

    Google Scholar 

  27. Young MRI, Young ME, Lozano Y and Bagash JM, 1992, Activation of protein kinase A increases the in vitroinvasion, migration, and adherence to reconstituted basement membrane by Lewis lung carcinoma tumor cells. Invasion Metastasis, 12,253–63.

    Google Scholar 

  28. Young MRI, Charboneau S, Lozano Y, Djordjevic A and Young ME, 1994, Activation of the protein kinase A signal transduction pathway by granulocytemacrophage colony-stimulating factor or by genetic manipulation reduces cytoskeletal organization in Lewis lung carcinoma variants. Int J Cancer, 54,446–51.

    Google Scholar 

  29. McKnight GS, Uhler MD, Clegg CH, Correll LA and Cadd GG, 1988, Application of molecular genetic techniques to the cAMP-dependent protein kinase system. Meth Enzymol, 159,299–311.

    Google Scholar 

  30. Maier GD, Wright MA, Lozano Y, Djordjevic A, Matthews JP and Young MRI, 1995, Regulation of cytoskeletal organization in tumor cells by protein phosphatases-1 and-2A. Int J Cancer, 61,51–4.

    Google Scholar 

  31. Babai F and Royal A, 1994, Rat myoblastic sarcoma cell lines. A model for the study of invasion, metastasis, and myogenic differentiation. Lab Invest, 70,907–15.

    Google Scholar 

  32. Gutierrez LM, Quintanar JL, Rueda J, Viniegra S and Reig JA, 1995, The protein phosphatase inhibitor calyculin-A affects catecholamine secretion and granular distribution in cultured adrenomedullary chromaffin cells. Eur J Cell Biol, 68,88–95.

    Google Scholar 

  33. Hannun YA and Linardic CM, 1993, Sphingolipid breakdown products: anti-proliferative and tumorsuppressor lipids. [Review] Biochim Biophys Acta, 1154,223–36.

    Google Scholar 

  34. Law B and Rossie S, 1995, The dimeric and catalytic subunit forms of protein phosphatase 2A from rat brain are stimulated by C2-ceramide. J Biol Chem, 270,12808–13.

    Google Scholar 

  35. Wolff RA, Dobrowsky RT, Bielawska A, Obeid LM and Hannun YA, 1994, Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J Biol Chem, 269,19605–9.

    Google Scholar 

  36. Dobrowsky RT, Kamibayashi C, Mumby MC and Hannun YA, 1993, Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem, 268,15523–30.

    Google Scholar 

  37. Okazaki T, Bielawska A, Bell RM and Hannun YA, 1990, Role of ceramide as a lipid mediator of 1α,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J Biol Chem, 265,15823–31.

    Google Scholar 

  38. Okazaki T, Bell RM and Hannun YA, 1989, Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem, 264,19076–80.

    Google Scholar 

  39. Berg JP, Ree AH, Sandvik JA, et al.1,25-Dihydroxyvitamin D3 alters the effect of cAMP in thyroid cells by increasing the regulatory subunit type IIb of the cAMP-dependent protein kinase. J Biol Chem, 269,pp32233-32238.

  40. Berg JP, Sandvid JA, Ree AH, et al.1994, 1,25-Dihydroxyvitamin D3 attenuates adenylyl cyclase activity in rat thyroid cells: reduction of thyrotropin receptor number and increase in guanine nucleotide-binding protein Gi-2a. Endocrinology, 135,595–602.

    Google Scholar 

  41. Colston KW, Makay AG, James SY, Binderup L and Chander S and Coombes RC, 1992, EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivoand in vitro. Biochem Pharmacol, 44,2273–80.

    Google Scholar 

  42. Shabahang M, Buras RR, Davoodi F, et al.1994, Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3. Cancer Res, 54,4057–64.

    Google Scholar 

  43. Studzinski GP and Moore DC, 1995, Sunlight-Can it prevent as well as cause cancer? Cancer Res, 55,4014–22.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pathology and Otolaryngology, Loyola University Stritch School of Medicine, Maywood, IL, USA

    M. Rita I. Young

  2. Department of Research Services, Hines V.A. Hospital Hines, Hines, IL, USA

    Yvonne Lozano

Authors
  1. M. Rita I. Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yvonne Lozano
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Young, M.R.I., Lozano, Y. Inhibition of tumor invasiveness by 1-alpha-25-dihydroxy-vitamin D coupled to a decline in protein kinase A activity and an increase in cytoskeletal organization. Clin Exp Metastasis 15, 102–110 (1997). https://doi.org/10.1023/A:1018492525027

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018492525027

Search

Navigation